Nicholas A. Smith

Array ( [id] => 5224692 [patent_doc_number] => 20070253958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Human monoclonal antibodies to FC gamma receptor II (CD32)' [patent_app_type] => utility [patent_app_number] => 11/731771 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33609 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253958.pdf [firstpage_image] =>[orig_patent_app_number] => 11731771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188001 [patent_doc_number] => 20070166309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'OPTIMIZED ANTI-CD30 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/686853 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 44124 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166309.pdf [firstpage_image] =>[orig_patent_app_number] => 11686853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367156 [patent_doc_number] => 20090304715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'MODIFIED ANTIBODIES WITH ENHANCED BIOLOGICAL ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 12/281437 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19933 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304715.pdf [firstpage_image] =>[orig_patent_app_number] => 12281437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5027924 [patent_doc_number] => 20070269371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Antibodies with altered effector functions' [patent_app_type] => utility [patent_app_number] => 11/713577 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28225 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269371.pdf [firstpage_image] =>[orig_patent_app_number] => 11713577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915162 [patent_doc_number] => 20080095762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'GLYCOPROTEIN COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/625201 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41425 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095762.pdf [firstpage_image] =>[orig_patent_app_number] => 11625201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591159 [patent_doc_number] => 07662926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/624523 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 83 [patent_no_of_words] => 41773 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662926.pdf [firstpage_image] =>[orig_patent_app_number] => 11624523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580540 [patent_doc_number] => 20090175886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST CD30 LACKING IN FUCOSYL AND XYLOSYL RESIDUES' [patent_app_type] => utility [patent_app_number] => 12/160990 [patent_app_country] => US [patent_app_date] => 2007-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 44335 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175886.pdf [firstpage_image] =>[orig_patent_app_number] => 12160990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5130731 [patent_doc_number] => 20070207128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Method for treating autoimmune diseases and compositions therefor' [patent_app_type] => utility [patent_app_number] => 11/653688 [patent_app_country] => US [patent_app_date] => 2007-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9907 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207128.pdf [firstpage_image] =>[orig_patent_app_number] => 11653688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977900 [patent_doc_number] => 20070219133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'CD52 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION' [patent_app_type] => utility [patent_app_number] => 11/618472 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 87286 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219133.pdf [firstpage_image] =>[orig_patent_app_number] => 11618472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062550 [patent_doc_number] => 20070224189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'CD20 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION' [patent_app_type] => utility [patent_app_number] => 11/618457 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 87785 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224189.pdf [firstpage_image] =>[orig_patent_app_number] => 11618457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988134 [patent_doc_number] => 20070154473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Anti-CD19 antibodies with reduced immunogenicity' [patent_app_type] => utility [patent_app_number] => 11/648505 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13123 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154473.pdf [firstpage_image] =>[orig_patent_app_number] => 11648505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004530 [patent_doc_number] => 20070202098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Her2/neu OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION' [patent_app_type] => utility [patent_app_number] => 11/618488 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 87797 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202098.pdf [firstpage_image] =>[orig_patent_app_number] => 11618488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797116 [patent_doc_number] => 20080008702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'ANTIBODY IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 11/612591 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9336 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008702.pdf [firstpage_image] =>[orig_patent_app_number] => 11612591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521412 [patent_doc_number] => 20090029393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'METHOD FOR PREPARING ANTIBODIES SELECTIVE FOR ACTIVATING FC RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/097022 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6997 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029393.pdf [firstpage_image] =>[orig_patent_app_number] => 12097022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530899 [patent_doc_number] => 20100221260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'IMMUNOGLOBULINS' [patent_app_type] => utility [patent_app_number] => 12/097279 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20710 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221260.pdf [firstpage_image] =>[orig_patent_app_number] => 12097279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988569 [patent_doc_number] => 20070154908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Connective Tissue Growth Factor-2' [patent_app_type] => utility [patent_app_number] => 11/563870 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10702 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154908.pdf [firstpage_image] =>[orig_patent_app_number] => 11563870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457856 [patent_doc_number] => 20090258008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Uses of the FcRn Receptor' [patent_app_type] => utility [patent_app_number] => 12/085067 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8974 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258008.pdf [firstpage_image] =>[orig_patent_app_number] => 12085067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045587 [patent_doc_number] => 20070264260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Treatment methods using anti-CD22 antibodies' [patent_app_type] => utility [patent_app_number] => 11/592750 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14267 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264260.pdf [firstpage_image] =>[orig_patent_app_number] => 11592750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999332 [patent_doc_number] => 20070041966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Polypeptides including modified constant regions' [patent_app_type] => utility [patent_app_number] => 11/588227 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9624 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041966.pdf [firstpage_image] =>[orig_patent_app_number] => 11588227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051343 [patent_doc_number] => 20070031888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1' [patent_app_type] => utility [patent_app_number] => 11/582264 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 123273 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031888.pdf [firstpage_image] =>[orig_patent_app_number] => 11582264 [rel_patent_id] =>[rel_patent_doc_number] =>)